Subscribe / Renew |
|
Contact Us |
|
► Subscribe to our Free Weekly Newsletter |
Construction Bids
home | Welcome, sign in or click here to subscribe. | login |
October 23, 2020
SILVER SPRINGS, Md. (AP) — The U.S. Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization.
The drug, which California-based Gilead Sciences is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.
. . .